Estrogen Reduces Risk of Alzheimer’s in Women

A study announced earlier this month at AAN’s 59th annual meeting shows that women who use hormone therapy before the age of 65 can cut their risk of developing Alzheimer’s disease or dementia. The study found that women who used any form of estrogen hormone therapy before the age of 65 were nearly 50 percent less likely to develop Alzheimer’s disease or dementia than women who did not use hormone therapy before age 65.
Researcher found that it didn’t matter how old the woman was when she started hormone therapy, how long or recently she took it or what kind of prior therapy she used. The reduced risk of dementia was seen only with prior hormone therapy, used before one’s enrollment in the study.